Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
The drug is being developed by Eli Lilly and Company, which has announced plans to progress retatrutide into Phase 3 clinical trials across multiple indications, including obesity, type 2 diabetes, and liver disease
Patients should be aware that research in this area is ongoing, and long-term safety and efficacy data may be limited for certain therapies
.webp)
Many are now horrified they have no idea what they were injecting into their bodies or the conditions under which the medication was manufactured
That does not mean it doesn't have that effect, just that the FDA hasn't determined that it does and approved it for that use
US$ 27.76
US$ 29.60
US$ 27.11
US$ 21.27
